Table 2 Treatment, complications, and outcome of COVID-19, and management of PTX/PM
Treatment | Complications | Outcome | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Dexamethasone 6.6 mg × 7–10 days | Methylprednisolone 1000 mg | ECMO day from PTX/PM | PPT | No of PPT before PTX/PM | Onset day after last PPT | ARDS | Management of PTX/PM | Death | ICU length of stay, in days | |
1 | − | − | 0 | + | 5 | 6 | + | Tube thoracotomy | − | 60 |
2 | − | + | 50 | + | 4 | 1 | + | Tube thoracotomy + bronchial occlusion | + | 88 |
3 | + | − | − | + | 1 | 8 | − | Conservative | − | 21 |
4 | − | + | − | + | 1 | 7 | + | Tube thoracotomy | − | 17 |
5 | + | − | − | + | 1 | 0 | − | Conservative | + | 6 |
6 | + | − | I0 | + | 1 | 2 | − | Tube thoracotomy + pleurodesis | − | 63 |
7 | + | − | 29 | + | 2 | 17 | + | Tube thoracotomy | − | 64 |
8 | + | + | -2 | + | 1 | 2 | + | Conservative | − | 75 |
9 | + | − | 11 | + | 4 | 1 | + | Tube thoracotomy | + | 40 |
10 | + | − | -1 | − | - | - | + | Tube thoracotomy | + | 17 |
11 | + | − | 11 | + | 3 | 12 | + | Conservative | + | 47 |
12 | + | + | -6 | + | 4 | 3 | + | Tube thoracotomy | + | 59 |
Median (IQR) | 2 (1–4) | 3 (1–8) | 53 (19–63.5) | |||||||